FDA
-
-
-
-
-
-
-
Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Citius Pharmaceuticals raises $5 million in registered direct offering
-
-
-
-
-
-
-
Citius Oncology reports positive phase 1 data for LYMPHIR cancer treatment
-
-
-
-
-
-
-
Citius Pharmaceuticals launches cancer drug LYMPHIR following FDA approval
-
-
-
-
-
-
-
Citius Oncology partners with Er-Kim for LYMPHIR distribution in Turkey, GCC
-
-
-
-
-
-
-
Citius Oncology to Advance Commercial Launch of LYMPHIR™ with Verix AI Integration
-
-
-
-
-
-
-
Citius Pharmaceuticals and Citius Oncology to Participate in Upcoming October 2025 Conferences
-
326,541 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

